Refine
Estimated Years UndatedClear
6,022 results foundRefine Search
1020.0001 Tab 3 3MA01933815 Io 1.~ 1.1 16 1020.0002 Tab 3 3MA01933816 o Plant~ p~ovld~ ~inE q~r~er~ fo~ ~he fiel~ e~ and rend~ other v~u~ble sssis~ee.
Document imageDocument imageDocument imageDocument image
refid# b35pmj2qDkdrzdzwGZkO70n325 pages
INTERIN SITE FOR DISPOSAL OF 3M CHEMOLITE WASTES INTERIN SITE FOR DISPOSAL OF 3 CHEMOLITE WASTES I.
Document imageDocument imageDocument imageDocument image
refid# O3nnGr6Ga6e7eMQNaQnbpE8Dj13 pages
Ta 145 1 MMIINNNNEE=SSOOTTAACOPPOUOLLPLLLUUATTIIINOOTNN RCCEOOPNNOTTRRRTOOLL AAGGEENNCCYY[o145rH COMPLAINT REPORT County:__ WWaasshhiinnggttoonn County : DDaattee RReecceeii'vveedd:: FFeebbrruuaarryy 1122,, 11998811 "city :_ CCoottttaaggee GGrroovvee TTiimmee RReecceeiivveedd:: AApppprrooxxiimmaatteellyy 11::3300 PP..uM..
Document image
refid# 0ggr06w35z0VyZDxr4JeZY6Qb1 page
ASFHTEEEA i i.z a Experizens Nous No. : CCoonntduucctteedd aA6t:: ---- Dosing Period; sSstuudtyy Ddiirreeccttoorr:s oral Oral Teratology Teratolo~7 sendy Study ooff F7C6--9355 iinn mRaa~css . o06s8s0oTrRm0o0o0s8 fRSsHriaaiakffkeeeeStrtsyyeLsaEaEpbvsvoioaarrltiaauuttaanoottrriliiioodeennssd,sLLabbITonoorcera.
Document imageDocument imageDocument imageDocument image
refid# KJkRrqoZZZqDoKvJ0wKDJrY0o33 pages
DDeecceemmbbeerr5,, 22001111 PPrroobbaabbllee LLiinnkk EEvvaalluuaattiioonn ooff PPrreeggnnaannccyy IInndduucceedd HHyyppeerrtteennssiioonn and and Preeclampsia, Preeclampsia `CPCaoonnneccli,luusswiioeonn;c: oOnOcnnuttdhheee tbbhaaassliistshooefrf eeeppiisiddaeepmmriooioblloaogbgilicce aainnnddk oobttehhteewrresseccniieenentxitipffiioccsuddaratetaataaovvPaaiFillaOabbAllee(ttCooE)tthhaeendCC.88 Science Science pPprraeenggennl,aanwncceyy--ciionnnddcuulccueeddde hypertension that there is a hypertension.
Document imageDocument imageDocument imageDocument image
refid# ba7rB3znQz0mXKqYRJqEDJVGg6 pages
FFCC TTooxxiicciittyy//SSaaffeettyy TTeessttiinngg IInn PPaarrttiiccuullaarr PPFFOOSS && NN--EEttFFOOSSEE ATTonoxdxiircceoowllooSggeyyacwwaoto,rrkkPabbueeliinnLggiedddooenrn,ee Maainndkd//eoorMr cccooNooarrmddaiinrnaaatt,eeddMbbayyrvDDeCeaaasnnenn,aaJNNoaahbbnbbeBefufetelelddn,,hoff Andrew Seacat, Paul Lieder, Mike McNamara, Mary Case, John Butenhoff AAnnaallyyttiiccaall wwoorrkk bbeeiinngg ddoonnee bbyy KKrriiss HHaannsseenn aanndd ccoo--wwoorrkkeerrss aatt EEnnvviirroonnmmeennttaall AAnnaallyyttiiccaall llaabboorraattoorryy ((BBLLDDGG 22)) aass wweellll aass FFrreeddDDee RRooooss iinn CCeennttrraall RReesseeaarrcchh ((BBLLDDGG 220011)) 3M Propicry normaion 3M PmprietatV Information econ Dec 98 Made Avalableby 3M for Inspection 2nd Copying as Confidential Informaien: Made Available by 3M for Inspection and Copying as Confidential Infornnati~n: SSuubbjjeecctt ttoo PPrrootteeccttiivvee OOrrddeerr IInn PPaallmmeerr vv.. 33MM,, NNoo..
Document imageDocument imageDocument imageDocument image
refid# 6RenBq4bgRKnbn1zBYGmm4eX921 pages
Template voorstellingsronde PFAS-saneringstechnieken Boskalis Environmental Max 7 minuten Techniek Boskalis Environmental (1) Belangrijkste technische aspecten van de PFAS-saneringstechniek Extractieve grondreiniging aangevuld met proceswaterbehandeling Proceswater (deels) behandelen met AK voor hergebruik Inzet vaste installaties op vergunde locaties - ca 700.000 ton per jaar (in Nederland) Inzet mobiele installatie op project locatie - ca 100 ton per uur (2 mobiele installaties) Technische voor- en nadelen Gebruik maken van bestaande infrastructuur, logistiek en equipment BBT waterbehandeling Niet geschikt voor alle PFAS, specifieke informatie per situatie is noodzakelijk Praktische ervaring met grootschalig gebruik van AK-filtratie SEIN, Se his , A5 N LNeSSON Erg~-- 3 payre, t Slaie id = _ a = " A Ex EB a a a e= a pa po \ a Wa - ES NY/ i v: a 4 Ee S ) NC iL Be 3 \ a wil a J iL
Document imageDocument imageDocument imageDocument image
refid# v6YQQ7JVaMKRZ4KE7bQdx18a810 pages
Document imageDocument imageDocument image
refid# zQKVegvp4bK7oOK2kk9Yq2JeB3 pages
/2 semi ; | p-------- R0e4v0d nSasoen -- | European Commission `D"A1G6v0eE,nneBvricuresosnBemeleasnutlieu 9 Subject: SEMI Stockholm Convention PFOA Recommendations DearJUL SEMI is very grateful for the consideration the POPRC has given in the past to our recommendations for specific exemptions toa listing of PFOA in Annex A.
Document imageDocument imageDocument image
refid# pen5NKo72e059BJJme440Ygkw3 pages
13 ym momma wer ay:Atlan Dba a MwiacrrodblaS.l RGiecnceitoi,csAsDseipsatratnmtenDtirector T acomerS s ne -- C--O SKI Project LSG-3145 Wibaw Oroiinees TTT on 1WG Bess STMMARY SRI International examined 34 Company's Compound T-3727 for muta= genic activity in the standard Anes Salmonella/microsome assay with strains TAIS35, TALS, TALS3S, TA98, and TALOD of the bacterium Salmonella typhimurius.
Document imageDocument imageDocument imageDocument image
refid# RJQdX8OaV0bD9pda4O2YQOdma16 pages
REPORT AMENDMENT NO. 1 | TWO YEAR ORAL(DIET) TOXICITY/CARCINOGENICITY STUDY OF FLUOROCHEMICAL FM-3924 IN RATS Experiment No.0281CR0012 The attached of the Summa pages include revisions in the first paragraph on page 3 The ry and revisions were in the third paragraph made to clarify of page 22 of the Discussion.
Document imageDocument imageDocument imageDocument image
refid# wDv68gyvgOKm1w6KKxLGDR4qB4 pages
ARA26 -- 147] + ' PERSONAL AND CONFIDENTIAL E 0: RC..
Document imageDocument imageDocument imageDocument image
refid# O3ekYKa9eaGbmxNw2B2yK7Gk124 pages
Lo. ." se am Lam KABA tt ert StaffaVicere, SEHR President __ 0399_ - 373 ee nARE-S0842 s A POBoxiN 3320n n.m Lo 9pose cb2 pay 19 27gedTR ay%q \, 0 Mr.
Document imageDocument imageDocument imageDocument image
refid# 6wdErKEBXK40YZnDmm0bQ2ov35 pages
~AR226-/7/6 CANCER PREVALENCE IN SUBJECTS EXPOSED TO PERFLUOROOCTANONIC ACID (PFOA) Jam ors es Dahlgren MD', Ayman B enero Torabim MD'*', Raphael Warshaw', seston Harpreet Takbar MPH' i.
Document image
refid# oQr0ZQmR5gd66BVRqnMRVy681 page
Form 10620-5-PWO CC: LAB REQUEST BOOK - 42-51111 PRODUCT ECOLOGICAL ASSESSMENT BACK TO MAIN n n Name: a G d . 4 - REQUESTER h5- Phone No.
Document imageDocument image
refid# NGg8VRpZvQ9V8kzL2KZEn255b2 pages